XML 39 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net income (loss) $ 132.9 $ (32.2)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Loss on discontinued operations and disposal 0.6 49.4
Depreciation and amortization 10.4 9.6
Write-off of deferred financing costs 4.5 3.5
Stock-based compensation expense 2.3 2.1
Pension expense, net of funding (1.2) (6.2)
Provision for doubtful accounts 0.2 0.3
Deferred income taxes, including changes in valuation allowance (91.3) 2.6
Changes in operating assets and liabilities, net of effects from dispositions of companies (21.1) (10.3)
Net cash provided by continuing operating activities 37.3 18.8
Net cash used for operating activities of discontinued operations (5.1) (21.1)
Net cash provided by (used for) operating activities 32.2 (2.3)
Investing activities:    
Purchases of properties and equipment (13.7) (9.2)
Proceeds from sales of properties and equipment 2.0 1.3
Proceeds from sale of FSTech Group 0 82.1
Decrease (increase) in restricted cash 1.0 (1.5)
Net cash provided by (used for) continuing investing activities (10.7) 72.7
Net cash provided by investing activities of discontinued operations      
Net cash provided by (used for) investing activities (10.7) 72.7
Financing activities:    
Increase (decrease) in revolving lines of credit, net 50.0 (173.1)
Decrease in short-term borrowings, net (0.3) (7.6)
Proceeds from issuance of long-term borrowings 75.0 215.0
Payments on long-term borrowings (150.7) (99.4)
Payments of debt financing fees (6.2) (6.9)
Other, net 1.8 2.3
Net cash used for continuing financing activities (30.4) (69.7)
Net cash used for financing activities of discontinued operations 0 (0.9)
Net cash used for financing activities (30.4) (70.6)
Effects of foreign exchange rate changes on cash and cash equivalents 0.1 (0.2)
Decrease in cash and cash equivalents (8.8) (0.4)
Cash and cash equivalents at beginning of period 29.7 9.5
Cash and cash equivalents at end of period $ 20.9 $ 9.1